Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Pathology Oncology Research : POR
|
July 14, 2021
Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma
Wentao Mu, Peng Su, Shanglei Ning
European Journal of Pharmacology
|
December 23, 2023
Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing
Shuxuan Li, Yao Zhi, Wentao Mu, et al.
Frontiers in Oncology
|
December 17, 2021
Long Noncoding RNA <i>SNHG1</i> Regulates <i>LMNB2</i> Expression by Sponging <i>miR-326</i> and Promotes Cancer Growth in Hepatocellular Carcinoma
Wentao Mu, Lingyu Guo, Yang Liu, et al.
ACS Applied Materials & Interfaces
|
July 15, 2023
Quantifying the Two-Dimensional Driving Patterns of Chemisorbed Oxygen and Particle Size on NO Reduction Activity and Mechanism
Wentao Mu, Shichao Ma, Hao Chen, et al.
Frontiers in Pharmacology
|
July 1, 2024
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
Wentao Mu, Yao Zhi, Jianpeng Zhou, et al.
Journal of the American Chemical Society
|
February 25, 2026
Modulating Intermediate Reactivity for Nitrogen Oxide Selective Catalytic Reduction through Dual Scaling Laws: A Synergetic <i>In Situ</i> Diffuse Reflectance Infrared Fourier Transform Spectroscopy and Density Functional Theory Study
Wentao Mu, Wenbiao Zhang, Shichao Ma, et al.
Pharmacological Research
|
November 10, 2023
Quenching thirst with poison? Paradoxical effect of anticancer drugs
Kaiyuan Chai, Chuanlei Wang, Jianpeng Zhou, et al.
International Journal of Oncology
|
April 3, 2020
Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma
Mingwen Jiao, Shanglei Ning, Jingbo Chen, et al.
Frontiers in Pharmacology
|
September 12, 2022
Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, et al.
Hepatology International
|
November 9, 2022
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Pathology Oncology Research : POR
|
July 14, 2021
Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma
Wentao Mu, Peng Su, Shanglei Ning
European Journal of Pharmacology
|
December 23, 2023
Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing
Shuxuan Li, Yao Zhi, Wentao Mu, et al.
Frontiers in Oncology
|
December 17, 2021
Long Noncoding RNA <i>SNHG1</i> Regulates <i>LMNB2</i> Expression by Sponging <i>miR-326</i> and Promotes Cancer Growth in Hepatocellular Carcinoma
Wentao Mu, Lingyu Guo, Yang Liu, et al.
ACS Applied Materials & Interfaces
|
July 15, 2023
Quantifying the Two-Dimensional Driving Patterns of Chemisorbed Oxygen and Particle Size on NO Reduction Activity and Mechanism
Wentao Mu, Shichao Ma, Hao Chen, et al.
Frontiers in Pharmacology
|
July 1, 2024
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
Wentao Mu, Yao Zhi, Jianpeng Zhou, et al.
Journal of the American Chemical Society
|
February 25, 2026
Modulating Intermediate Reactivity for Nitrogen Oxide Selective Catalytic Reduction through Dual Scaling Laws: A Synergetic <i>In Situ</i> Diffuse Reflectance Infrared Fourier Transform Spectroscopy and Density Functional Theory Study
Wentao Mu, Wenbiao Zhang, Shichao Ma, et al.
Pharmacological Research
|
November 10, 2023
Quenching thirst with poison? Paradoxical effect of anticancer drugs
Kaiyuan Chai, Chuanlei Wang, Jianpeng Zhou, et al.
International Journal of Oncology
|
April 3, 2020
Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma
Mingwen Jiao, Shanglei Ning, Jingbo Chen, et al.
Frontiers in Pharmacology
|
September 12, 2022
Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, et al.
Hepatology International
|
November 9, 2022
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, et al.
Page
of 2